Recordati Group

About Recordati Group

Recordati Group is a prominent international pharmaceutical company headquartered in the UK, dedicated to the research, development, manufacturing, and marketing of innovative medicines. Established in 1926, the company has a rich history of providing high-quality healthcare solutions that address unmet medical needs.

With a strong focus on rare diseases and specialty pharmaceuticals, Recordati aims to improve the quality of life for patients worldwide. The company’s extensive portfolio includes treatments for various therapeutic areas, including cardiovascular, urology, and central nervous system disorders.

Recordati Group operates in over 30 countries and has a significant presence in Europe, North America, and emerging markets. The company is committed to sustainable practices and invests heavily in research and development to foster innovation and enhance patient care.

In addition to its pharmaceutical activities, Recordati is also involved in the production of active pharmaceutical ingredients (APIs), ensuring the highest standards of quality and compliance. The company collaborates with healthcare professionals and organizations to promote awareness and education about rare diseases.

Recordati Group’s vision is to be a leader in the pharmaceutical industry by delivering effective and safe therapies while maintaining a strong ethical commitment to patients and stakeholders. The company values integrity, excellence, and teamwork, which are reflected in its corporate culture.

As part of its corporate social responsibility initiatives, Recordati actively participates in community engagement and supports various health-related programs. The company’s dedication to improving global health outcomes is evident in its ongoing efforts to expand access to essential medicines.

Overall, Recordati Group stands out as a trusted partner in the healthcare sector, driven by a passion for innovation and a commitment to making a positive impact on patients’ lives.